增强Deinagkistrodon acutus通过补充阿库托利辛A向抗体来增强抗毒功效
Chien-Chun Liu1,2,3, Yu-Shao Chou4, Yi-Xiu Yang5
1The School of Public Health and Medical Technology, Xiamen Medical College, Xiamen, Fujian, China.
PLoS neglected tropical diseases
|December 12, 2025
概括
向抗体治疗可以改善Deinagkistrodon acutus抗毒药的疗效. 补充低强度抗毒剂与抗阿库托利辛A抗体显著增强了小鼠的中和,验证了它们的关键作用.
科学领域:
- 生物化学 生物化学
- 免疫学 免疫学 免疫学
- 毒理学 毒理学 毒理学
背景情况:
- 抗毒药生产面临的挑战是,中和功能的批量变化.
- 台湾的Deinagkistrodon acutus抗毒制造显示出不一致的马类免疫结果.
- 降低的疗效可能源于对关键的金属蛋白酶毒素阿库托利辛A的低抗体标位.
研究的目的:
- 为了研究抗阿库托利辛A抗体在D. acutus抗毒药的有效性中的作用.
- 探索增强抗毒素中抗氧化素A抗体水平的方法.
- 评估基于抗体的策略,以提高抗毒药的功效.
主要方法:
- 从D. acutus毒液中净化了阿库托利辛A,使用两步HPLC.
- 从高强度马类血中通过亲缘性染色学分离出特定抗体.
- 补充了抗体的低强度血,并在小鼠致死模型中进行了测试.
- 在马群免疫接种期间,评估了用净化阿库托利辛A的补充增强剂.
主要成果:
- 补充低强度血与抗阿库托利辛A抗体改善了小鼠的存活率.
- 这提供了体内证据,证明抗阿库托利辛A抗体对抗毒药疗效至关重要.
- 补充增强增加了抗急素A标位,但缩小了抗原宽度.
结论:
- 抗阿库托利辛A抗体是D. acutus抗毒药效力的关键决定因素.
- 有针对性的抗体补充可以提高抗毒中和效率.
- 基于抗体的增强提供了一种潜在的策略,以提高D. acutus的抗毒性.
相关概念视频
Prevention of Further Absorption of Poison
1.2K
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
1.2K
Antidotes
1.0K
Antidotes are medicinal substances used to counteract the harmful effects of toxins or drugs in the body. They function in various ways, each uniquely designed to combat specific toxic compounds.
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
1.0K
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
1.1K
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
1.1K


